Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-26 Purchase | 2022-05-31 5:17 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 43,900 | $0.18188 | $7,985 | 585,248 (Indirect Direct) | View |
| 2022-03-03 Purchase | 2022-03-09 4:01 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 139,488 | $0.391 | $54,540 | 249,674 (Direct) | View |
| 2021-08-17 Purchase | 2021-08-17 4:08 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 4,000 | $0.8955 | $3,582 | 102,247 (Indirect) | View |
| 2020-08-19 Purchase | 2020-08-20 07:59 am | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 2,000 | $1.01 | $2,020 | 2,000 (Indirect) | View |
| 2020-02-11 Purchase | 2020-02-12 9:32 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 2,175 | $1.15 | $2,501 | 81,546 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-11 Option Award | 2024-04-12 4:50 pm | 2025-04-11 2034-04-11 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:04 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 14,300 | $0 | 49,135 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:33 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,000 | $0 | 34,835 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-12-12 6:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 2,693 | $1.734 | 14,835 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-11-08 5:42 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 22,142 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-07 4:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 313,574 (Direct) | View |
| 2022-05-03 Option Award | 2022-05-05 4:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $0.1863 | 259,674 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-21 4:08 pm | N/A 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-11-03 Option Award | 2021-11-05 2:58 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 7,939 | $0.718 | 110,186 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 5:10 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 9,822 | $0.567 | 96,247 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-04 5:05 pm | N/A 2030-12-01 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2020-11-03 Option Award | 2020-11-05 5:44 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 4,879 | $0.561 | 86,425 (Direct) | View |
| 2020-07-14 Option Award | 2020-07-16 8:56 pm | N/A 2030-07-13 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 339,584 | $0 | 339,584 (Direct) | View |
| 2020-03-23 Option Award | 2020-03-25 6:02 pm | N/A 2030-03-22 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 60,000 | $0 | 60,000 (Direct) | View |